HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corneal Collagen Cross-Linking for Late Onset Progressive Keratoconus in Iridocorneal Endothelial Syndrome.

AbstractPURPOSE:
The aim of this study was to report the first case of successful use of corneal collagen cross-linking (CXL) to halt the progression of keratoconus in a patient with concurrent iridocorneal endothelial (ICE) syndrome.
METHODS:
A 30-year-old White man was referred to our subspecialty corneal clinic for further investigation of right corectopia. The patient was asymptomatic and was otherwise fit. Slit-lamp examination revealed a right oval-shaped pupil decentered superiorly, a transillumination defect at the 5-o'clock position, minimal gutta-like changes in the corneal endothelium, and few inferior peripheral anterior synechiae. Dilated fundoscopy was normal in both eyes, with healthy optic discs, maculae, and peripheral retinae. Specular microscopy and slit-lamp findings suggested ICE syndrome. Subsequent investigation with corneal tomography showed progressive signs of inferior corneal ectasia with steepening, and thinning in the right eye, consistent with keratoconus. The left eye was unremarkable.
RESULTS:
Epithelium-off accelerated corneal CXL was performed in the affected eye. Early post-CXL follow-up (1 week) was unremarkable, and further follow-ups were arranged at 3, 6, 12, and 24 months, respectively. In subsequent reviews, the patient's vision and corneal tomography findings were stable.
CONCLUSIONS:
We describe the first case of corneal CXL for progressive keratoconus with ICE syndrome. co-existing keratoconus and ICE syndrome can occur, and corneal cross-linking was used successfully in this case to halt keratoconus progression. However, further studies will need to establish the impact of epithelium-off corneal cross-linking, especially in more severely affected eyes.
AuthorsMaria Phylactou, Nizar Din, Francesco Aiello, Romesh Angunawela
JournalCornea (Cornea) Vol. 42 Issue 10 Pg. 1293-1296 (Oct 01 2023) ISSN: 1536-4798 [Electronic] United States
PMID37170404 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Chemical References
  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Riboflavin
Topics
  • Male
  • Humans
  • Adult
  • Keratoconus (drug therapy)
  • Iridocorneal Endothelial Syndrome
  • Corneal Cross-Linking
  • Corneal Stroma
  • Ultraviolet Rays
  • Visual Acuity
  • Cross-Linking Reagents (therapeutic use)
  • Photosensitizing Agents (therapeutic use)
  • Riboflavin (therapeutic use)
  • Corneal Topography
  • Photochemotherapy (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: